Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126573621 | 12657362 | 1 | I | 20160805 | 20160816 | 20160816 | PER | US-BAYER-2016-153863 | BAYER | 65.00 | YR | E | M | Y | 97.50000 | KG | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126573621 | 12657362 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | 1 ML, QOD | 103471 | 1 | ML | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||||
| 126573621 | 12657362 | 2 | SS | BETASERON | INTERFERON BETA-1B | 1 | 0.75 ML, QOD | 103471 | .75 | ML | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||||
| 126573621 | 12657362 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0000079430 | 0 | 10 | MG | BID | ||||||
| 126573621 | 12657362 | 4 | C | MECLIZINE HCL | MECLIZINE HYDROCHLORIDE | 1 | 12.5 MG, UNK | 0 | 12.5 | MG | |||||||||
| 126573621 | 12657362 | 5 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 60 MG, TID | 0 | 60 | MG | TID | ||||||||
| 126573621 | 12657362 | 6 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 126573621 | 12657362 | 7 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 126573621 | 12657362 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 5000 IU, QD | 0 | 5000 | IU | QD | ||||||||
| 126573621 | 12657362 | 9 | C | LESCOL | FLUVASTATIN SODIUM | 1 | 80 MG, QD | 0 | 80 | MG | QD | ||||||||
| 126573621 | 12657362 | 10 | C | POTASSIUM CITRATE. | POTASSIUM CITRATE | 1 | 10 MEQ, UNK | 0 | 10 | MEQ | |||||||||
| 126573621 | 12657362 | 11 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 126573621 | 12657362 | 12 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | 0.4 MG, BID | 0 | .4 | MG | BID | ||||||||
| 126573621 | 12657362 | 13 | C | ROPINIROLE. | ROPINIROLE | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | |||||||||
| 126573621 | 12657362 | 14 | C | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, HS | 0 | 100 | MG | QD | ||||||||
| 126573621 | 12657362 | 15 | C | KLONOPIN | CLONAZEPAM | 1 | 0.5 MG, HS | 0 | .5 | MG | QD | ||||||||
| 126573621 | 12657362 | 16 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 10 MG, HS | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126573621 | 12657362 | 1 | Multiple sclerosis |
| 126573621 | 12657362 | 2 | Multiple sclerosis |
| 126573621 | 12657362 | 3 | Gait disturbance |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126573621 | 12657362 | Concussion | |
| 126573621 | 12657362 | Contusion | |
| 126573621 | 12657362 | Dizziness | |
| 126573621 | 12657362 | Drug ineffective | |
| 126573621 | 12657362 | Fall | |
| 126573621 | 12657362 | Gait disturbance | |
| 126573621 | 12657362 | Head injury | |
| 126573621 | 12657362 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |